Natixis

Marketing began this week for leveraged loans of €725m backing the merger of French private healthcare groups Vedici and Vitalia.

Bolloré and Eurofins Scientific became the first unrated names to tap the euro market in July this week, showing that the market is back on track by drawing comfortably oversubscribed trades.

The primary market for peripheral European covered bonds leapt back to life this week after a 12 week hiatus, with investors queuing up to buy a series of deals that emerged in quick succession.

Unrated French issuer Bolloré sold its second ever euro deal on Wednesday, drawing a strong order book that bodes well for Eurofins Scientific, another unrated corporate that could tap the market as soon as Thursday.

Three companies on Tuesday added to the prospects for corporate bond issuance in Europe this week. Bolloré and RWE are set to complete deals roadshowed in June while Eurofins scientific has given a new mandate.

DomusVi, the French operator of private care homes for the elderly, announced on Tuesday a €125m tap of its subsidiary HomeVi’s only high yield bond, as it is acquiring Geriatros from private equity fund Magnum.

Cellnex Telecom, the broadcasting tower business floated by Abertis Infraestructuras in May, marketed and sold its first bond issue on Monday, raising €600m.

Leveraged loans of €725m backing the merger of French private healthcare groups Vedici and Vitalia are being marketed at a bank meeting today.

The corporate bond pipeline is swelling again as Transport et Infrastructures Gaz France, the French gas distribution and storage company, mandated banks on Monday for its second ever euro deal.

Natixis has appointed Pascal Soldaini to a CEEMEA focused position in its global infrastructure and projects business.

Aéroports de Paris reopened the corporate bond market on Wednesday after two weeks’ silence, using an attractive new issue premium to amass a hefty order book for a €500m deal.

German wheelchair maker Sunrise Medical’s €315m acquisition loan has begun trading in secondary markets after being priced in line with initial guidance.